· Daily · Newsletters
Resonance network: Quantum InsiderSpace Insider
Insider Brief RevolKa has secured 250 million JPY (US$1.7M) in Series A extension funding to advance its AI-driven protein engineering platform, aiProtein®, and launched a drug discovery program for rare diseases. The funds, co-led
The daily briefing on LinkedIn. Free, one tap to follow.
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.